Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04487522 · ClinicalTrials.gov registry record
Pain and Quality of Life After Retromuscular Ventral Hernia Repair (RECOVER)
A clinical trial of Ventral Hernia, sponsored by Intuitive Surgical.
- Completed
- Registry status
- 74
- Enrollment target
- 4
- Study locations
NCT04487522: Completed study of Ventral Hernia, sponsored by Intuitive Surgical.
NCT04487522 is a study of Ventral Hernia that has completed, run by Intuitive Surgical. The registered enrollment target is 74 participants, below the 139-participant average among 18 other Ventral Hernia trials with a reported enrollment target (47% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04487522, a study of Ventral Hernia, has completed, sponsored by Intuitive Surgical.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
- 4
- Study locations
Study Summary
The study aims to explore the difference in outcomes relating to pain and quality of life after open, laparoscopic, and robotic-assisted retromuscular ventral hernia repair.
Primary Outcome
Subject reported pain scores assessed by the Subject-Reported Outcome Measurement Information System (PROMIS) Pain Intensity 3a survey.
Conditions Studied
Interventions
- PROCEDURE Open retromuscular ventral hernia repair
- PROCEDURE Laparoscopic retromuscular ventral hernia repair
- DEVICE Robotic-assisted retromuscular ventral hernia repair
Study Locations (4)
California
- Kaiser Foundation Research Institute, Oakland/Richmond - Oakland
- Kaiser Foundation Research Institute, South Sacramento - Sacramento
- Kaiser Foundation Research Institute, Santa Clara - Santa Clara
- Kaiser Foundation Research Institute, Walnut Creek - Walnut Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2020-07-16 |
| Est. Completion | 2024-09-19 |
What the finished NCT04487522 record still lists
NCT04487522 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 139-participant average among 18 other Ventral Hernia trials with a reported enrollment target (47% lower).
The record links to 1 condition, with Ventral Hernia appearing as the primary indexed condition, and to 3 interventions - of which Open retromuscular ventral hernia repair is the first listed.
NCT04487522 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04487522 about?
NCT04487522 is a clinical study titled "Pain and Quality of Life After Retromuscular Ventral Hernia Repair (RECOVER)". The study aims to explore the difference in outcomes relating to pain and quality of life after open, laparoscopic, and robotic-assisted retromuscular ventral hernia repair.
What is the current status of trial NCT04487522?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2020-07-16. Estimated completion is 2024-09-19.
What conditions does trial NCT04487522 study?
This clinical trial studies the following conditions: Ventral Hernia.
What interventions are being tested in trial NCT04487522?
The interventions under investigation include: Open retromuscular ventral hernia repair (PROCEDURE), Laparoscopic retromuscular ventral hernia repair (PROCEDURE), Robotic-assisted retromuscular ventral hernia repair (DEVICE).
Who is sponsoring clinical trial NCT04487522?
This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04487522 being conducted?
This trial has 4 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventral Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04487522's enrollment target sits among peer trials
74 14th of 18 higher than 5 of 18 other Ventral Hernia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ventral Hernia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair
RECRUITING · NA
-
Robotic Versus Open Ventral Hernia Repair
RECRUITING · NA
-
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair
RECRUITING · Phase 2
-
Clinical Investigation of the da Vinci Surgical System
ACTIVE NOT RECRUITING · NA
-
Post-operative Pain Control-TAP Block Using Exparel vs. Marcaine for Hernia Repairs
ACTIVE NOT RECRUITING · Early Phase 1
-
Methocarbamol in Ventral and Inguinal HR
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI